$ 147.69
2.65% (24h)
0.001798 BTC
3.43% (24h)
179,886 satoshies
atlContract
ao
0xf1d...1a76fd
Info
Asset | 1h | 24h | 7d | 1m | 1y | max |
|---|---|---|---|---|---|---|
rxbi | - | - | - | - | - | - |
SPDR S&P Biotech ETF Tokenized Stock (Reality) Price Statistics
Market Cap Rank
#10400
Market Cap
5,902.0106 $
Circulating Supply
39.96
Total Supply
39.96
Max Supply
-
Fully Diluted Valuation
$ 2,751.45
24 Hour Trading Vol
43.2647 $
24h Low / 24h High
0/0
All-Time High
162.22
-8.95%
22 September, 2026, (a month ago)
All-Time Low
143.68631383000002
2.78%
16 October, 2026, (3 days ago)
SPDR S&P Biotech ETF Tokenized Stock (Reality) Performance
Trading Pair
day
week
month
rxbi / usd
2.65%
-1.38%
-5.44%
rxbi / btc
3.43%
0.61%
-7.21%
rxbi / eth
3.4%
3.66%
1.24%
About Coin
Tracks the S&P Biotechnology Select Industry Index, offering exposure to the U.S. biotechnology segment using an equal-weighted methodology.
What is the highest value SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI) has ever reached?
SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI) reached its peak price at 162.22 $ on 22 September 2026, approximately a month ago. Presently, the current price is -8.95% lower than this all-time high.
What is the historical minimum price for SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI)?
The minimum price reached for SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI) was 143.6863 $, documented on 16 October 2026, more than 3 days ago. In comparison, the current price is 2.78%, it above this historical low.
What is the fully diluted valuation of SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI)?
The fully diluted valuation (FDV) of SPDR S&P Biotech ETF Tokenized Stock (Reality) (RXBI) stands at $ 2,751.45. This figure reflects the maximum potential market capitalization, considering that the current circulating supply is at its maximum of RXBI tokens. The realization of this FDV might take several years depending on the emission schedule of RXBI tokens.
IMPORTANT DISCLAIMER: The information presented on our website and associated platforms is sourced from third parties and is intended for general informational purposes only. We do not guarantee the accuracy or timeliness of this content. None of the information provided should be construed as financial, legal, or other professional advice tailored to your specific needs. Your use of this content is at your own discretion and risk. It's important to independently research, evaluate, and verify the information before relying on it. Trading carries significant risks, so it's advisable to consult with a financial advisor before making any decisions. Our content is not intended to solicit or offer any services.
